The UHPLC was performed on a Waters
Acauity UHPLC system (Waters, Milford, MA), which was equipped with
a binary solvent delivery manager, column manager, and sample manager
coupled to
ELSD and UV detectors (Waters, Milford, MA). Detection
was performed on a Waters
LCT premier XE mass spectrometer (Waters,
Milford, MA). The instrument was fitted with an Acquity Bridged Ethane
Hybrid (BEH) C18 column (30 mm × 2.1 mm, 1.7 μm particle
size, Waters, Milford, MA) operated at 60 °C.
Brodney M.A., Beck E.M., Butler C.R., Barreiro G., Johnson E.F., Riddell D., Parris K., Nolan C.E., Fan Y., Atchison K., Gonzales C., Robshaw A.E., Doran S.D., Bundesmann M.W., Buzon L., Dutra J., Henegar K., LaChapelle E., Hou X., Rogers B.N., Pandit J., Lira R., Martinez-Alsina L., Mikochik P., Murray J.C., Ogilvie K., Price L., Sakya S.M., Yu A., Zhang Y, & O’Neill B.T. (2015). Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug–Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors. Journal of Medicinal Chemistry, 58(7), 3223-3252.